blood sampling: One blood sample wiil be collected into a 10mL K2EDTA BD Vacutainer® tube
Study summary
The goal of this observational study is to evaluate the expression of miR-10a-5p in the blood in patients with sexual addiction or food addiction. The main question it aims to answer is : To determine whether adults patients with SA or FA exhibit a distinct blood miR-10a-5p expression profile compared with matched healthy controls.
For all participants, one blood sample will be collected.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion criteria
For patients with FA:
* Male and females ≥ 18 years old
* Already in care or newly initiating care
* Participating to EVALADD cohort
* Current diagnosis of FA
* Oral consent provided
* Affiliated with French social security system or beneficiary from such system
For healthy controls matched to patients with FA:
* Male and females ≥ 18 years old
* Oral consent provided
* Affiliated with French social security system or beneficiary from such system
For patients with SA:
* Male ≥ 18 years old
* Already in care or newly initiating care
* Participating to EVALADD cohort
* Current diagnosis of SA
* Oral consent provided
* Affiliated with French social security system or beneficiary from such system
For healthy controls matched to patients with SA:
* Male ≥ 18 years old
* Oral consent provided
* Affiliated with French social security system or beneficiary from such system
Exclusion Criteria :
For patients with FA:
* Presence of a current diagnosis of SA
* Presence of any current addictive disorder (substance \[except tobacco\] use disorders, gambling disorder, gaming disorder)
* Presence of any current instable psychiatric disorder (requiring the initiation or adapation of medication)
* Pregnancy or breastfeeding woman
* Trusteeship or curatorship
* Major cognitive impairment
* Not fluent in French
For patients with SA:
* Presence of a current diagnosis of FA
* Presence of any current addictive disorder (substance \[except tobacco\] use disorders, gambling disorder, gaming disorder)
* Presence of any current instable psychiatric disorder (requiring the initiation or adapation of medication)
* Trusteeship or curatorship
* Major cognitive impairment
* Not fluent in French
For healthy controls:
* Without a current diagnosis of FA
* Without a current diagnosis of SA
* Presence of any current addictive disorder (substance \[except tobacco\] use disorders, gambling disorder, gaming disorder)
* Presence of any current instable psychiatric disorder (requiring the initiation or adapation of medication)
* Pregnancy or breastfeeding woman
* Trusteeship or curatorship
* Major cognitive impairment
* Not fluent in French
Primary outcome measure(s)
Blood miR-10a-5p expression — 3 months The concentration of each miR-enriched fraction will be determined by spectrophotometric between patients with SA or FA and matched healthy controls.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
